Form 8-K - Current report:
SEC Accession No. 0001628280-25-031304
Filing Date
2025-06-13
Accepted
2025-06-13 16:06:56
Documents
13
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dna-20250612.htm   iXBRL 8-K 44301
  Complete submission text file 0001628280-25-031304.txt   198376

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20250612.xsd EX-101.SCH 2196
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20250612_def.xml EX-101.DEF 15512
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20250612_lab.xml EX-101.LAB 27403
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20250612_pre.xml EX-101.PRE 16190
16 EXTRACTED XBRL INSTANCE DOCUMENT dna-20250612_htm.xml XML 3377
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 251046547
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)